Skip to main content
Log in

Platelet activation by endogenous 5-hydroxytryptamine and histamine released by mast cell degranulation with compound 48/80 in the rat

  • Platelets and Thrombosis
  • Published:
Agents and Actions Aims and scope Submit manuscript

Abstract

The intravenous injection of the mast cell degranulator C 48/80 (1 mg/kg) in rats did not produce thrombocytopenia nor circulating platelet aggregates but sensitized the platelets to aggregate upon turbulence challenge. Such turbulence-induced platelet aggregation was not accompanied by formation of thromboxane B2. Electron microscopy revealed absence of platelet degranulation. Turbulence-induced platelet aggregation was completely prevented by pre-treatment of the rats with cyproheptadine, dipyridamole and VK 774, partially with ketanserin (5HT2-receptor antagonist), but not with methysergide (anti-serotonergic drug), pyrilamine (antihistaminic drug), suprofen, aspirin (cyclo-oxygenase inhibitors), phentolamine, propranolol, flunarizine, lidoflazine, oxycoumarin or Trasylol®. Combined treatment with the anti-histaminic drug pyrilamine and the 5HT2-receptor antagonist ketanserin resulted in a dose-related inhibition for ketanserin of the turbulence-induced platelet aggregation. These experiments point to an interaction between histamine and 5-hydroxytryptamine in the platelet activation by mast cell released mediators.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. K.A. Knauer, L.M. Lichtenstein, N.F. Adkinson andJ.E. Fisch,Platelet activation during antigen induced airway reactions in asthmatic subjects, New Engl. J. Med.304, 1404–1407 (1981).

    PubMed  Google Scholar 

  2. J.L. David andF. De Clerck, Detection of platelet activationin vivo: significance and limitations of the available tests. In5-Hydroxytryptamine in Peripheral Reactions, (Eds.F. De Clerck andP.M. Vanhoutte). Raven Press, New York 1982 (in press).

    Google Scholar 

  3. K.M. McLaren, L. Holloway andD.S. Pepper,Human platelet factor 4 and tissue mast cells, Thromb. Res.12, 293–297 (1980).

    Article  Google Scholar 

  4. G. Cella andA. Girolami,Platelet activation in antigen-induced bronchoconstriction, New Engl. J. Med.305, 842–893 (1981).

    Google Scholar 

  5. B.B. Vargaftig, M. Chignard andJ. Benveniste,Present concepts on the mechanisms of platelet aggregation, Biochem. Pharmac.30, 263–271 (1981).

    Article  Google Scholar 

  6. F. De Clerck andJ.L. David,Pharmacological control of platelet and red blood cell function in the microcirculation, J. Cardiovasc. Pharmac.3, 1388–1412 (1981).

    Google Scholar 

  7. L.M. McManus, C.A. Morley, S.P. Levine andR.N. Pinckard,Platelet activating factor (PAF) induced release of platelet factor 4 (PF 4)in vitro and during IgE anaphylaxis in the rabbit, J. Immun.123, 2835–2841 (1979).

    PubMed  Google Scholar 

  8. B.B. Vargaftig, M. Chignard, J. Lefort andJ. Benveniste,Platelet-tissue interaction: role of platelet activating factor (PAF-acether), Agents and Actions,10, 502–506 (1980).

    Article  PubMed  Google Scholar 

  9. H.H. Newball, R.W. Berninger, R.C. Talamo andL.M. Lichtenstein,Anaphylactic release of a basophil kallikrein-like activity. I. Purification and characterization, J. clin. Invest.64, 457–465 (1979).

    PubMed  Google Scholar 

  10. N.F. Adkinson, H.H. Newball, S. Findlay, K. Adams andL.M. Lichtenstein,Anaphylactic release of prostaglandins from human lung in vitro, Am. Rev. resp. Dis.121, 911–920 (1980).

    PubMed  Google Scholar 

  11. F. Sicuteri,Mast cells and their active substances: their role in the pathogenesis of migraine, Headache3, 86–92 (1963).

    Article  Google Scholar 

  12. F. De Clerck, J.L. David andP.A.J. Janssen,Inhibition of 5-hydroxytryptamine-induced and-amplified human platelet aggregation by ketanserin (R 41 468), a selective 5HT 2-receptor antagonist, Agents and Actions,12, 388–397, 1982.

    Article  PubMed  Google Scholar 

  13. B.K. Bhattacharya andG.P. Lewis,The release of 5-hydroxytryptamine by histamine liberators, Br. J. Pharmac.11, 202–208 (1956).

    Google Scholar 

  14. F. Awouters, C.J.E. Niemegeers andP.A.J. Janssen,Inhibition of mast cell-mediated shock in the rat: relationships to histamine and serotonin antagonism, Drug Dev. Res.1, 107–114 (1981).

    Article  Google Scholar 

  15. J.M. Van Nueten, P.A.J. Janssen, J. Van Beek, R. Xhonneux, T. Verbeuren andP.M. Vanhoutte,Vascular effects of ketanserin (R 41 468), a novel antagonist of 5HT 2 serotonergic receptors, J. Pharmac. exp. Thér.218, 217–229 (1981).

    Google Scholar 

  16. J. Hladovec andF. De Clerck,Protection by flunarizine against endothelial cell injury in vitro, Angiology32, 448–462 (1981).

    PubMed  Google Scholar 

  17. F. De Clerck, L. Van Gorp andR. Xhonneux,Effects of lorcainide, a new antiarrhythmic compound, on the changes in heart rhythm induced by intravenous injection of adenosine-5′-diphosphate in rats, Archs int. Pharmacodyn. Thér.231, 222–231 (1978).

    Google Scholar 

  18. T.S. Burns andR.N. Saunders,Quantitation of in vivo platelet aggregation by the platelet aggregate ratio method, Thromb. Res.10, 629–633 (1977).

    Article  PubMed  Google Scholar 

  19. F. De Clerck, J. Goossens andR. Reneman,Effects of anti-inflammatory, anticoagulant and vasoactive compounds on tail bleeding time, whole blood coagulation time and platelet retention by glass beads in rats, Thromb. Res.8, 179–193 (1976).

    Article  Google Scholar 

  20. F. De Clerck,Effects of lidoflazine (R 7904) on human platelet function in vitro, Thromb. Diath. haemorrh.28, 228–236 (1972).

    PubMed  Google Scholar 

  21. J. Caen, M.J. Larrieu andM. Samama,L'Hémostase. Méthodes d'exploration et diagnostique pratique, Expans. Rech. scient., Paris 98–107 (1968).

  22. F. De Clerck, L. Van Gorp, Y. Somers andB. Xhonneux,Effects of ketanserin, a selective 5HT 2-receptor antagonist, on platelet function, plasma coagulation, fibrinolysis and haemostasis in the rat (in preparation, 1982).

  23. F. Geeraerts, L. Schimpfessel andR. Crokaert,A simple routine-method to preserve and determine blood serotonin, Experientia30, 837 (1974).

    Article  Google Scholar 

  24. W.D.M. Patton,Compound 48/80: a potent histamine liberator, Br. J. Pharmac.6, 499–508 (1951).

    Google Scholar 

  25. A. Oliveira, Lima,Pharmacologically active substances released during anaphylactic shock in the mouse, Int. Archs Allergy32, 46–54 (1967).

    Google Scholar 

  26. S.W. Levy andL.B. Jacques,Appearance of heparin antithrombin-active chains in vivo after injection of commercial heparin and in anaphylaxis, Thromb. Res.13, 429–441 (1978).

    Article  PubMed  Google Scholar 

  27. R.A. Lewis andK.F. Austen,Nonrespiratory functions of pulmonary cells: the mast cell, Fed. Proc.36, 2676–2683 (1977).

    PubMed  Google Scholar 

  28. B. Humberger, B.B. Fredholm andL.O. Farnebo,Anaphylaxis and plasma catecholamines, Life Sci.26, 1465–1471 (1980).

    Article  PubMed  Google Scholar 

  29. S.F. Mohammad, W.H. Anderson, J.B. Smith, M.Y.K. Chuang andR.G. Mason,Effects of heparin on platelet aggregation and release and thromboxane A2 production, Am. J. Pathol.104, 132–141 (1981).

    PubMed  Google Scholar 

  30. P. Zatti,Azione agglutinante dell' istamina sulle piastrine, Boll. Soc. ital. Biol. sper.28, 1034–1035 (1952).

    PubMed  Google Scholar 

  31. J. Lecomte andY. Bounameaux,Libération d'histamine et agglutination des thrombocytes, Acta allerg.8, 189–197 (1955).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

De Clerck, F., Somers, Y., Van Gorp, L. et al. Platelet activation by endogenous 5-hydroxytryptamine and histamine released by mast cell degranulation with compound 48/80 in the rat. Agents and Actions 13, 81–87 (1983). https://doi.org/10.1007/BF01994287

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01994287

Keywords

Navigation